Back to Search
MANU GUJRATI, MD
MD
Plastic Surgery within the Head & Neck (Otolaryngology) Physician
NPI: 1720230451Individual
Specialties, Licenses & Credentials
Otolaryngology Physician
Otolaryngology
Code: 207Y00000X
MD 29049(AL)
Plastic Surgery within the Head & Neck (Otolaryngology) PhysicianPrimary
Otolaryngology — Plastic Surgery within the Head & Neck
Code: 207YX0007X
A112446(CA)
Research & Publications (20)
Neuronal apoptosis is inhibited by cord blood stem cells after spinal cord injury.
PMID 19469692·J Neurotrauma·2009
7-preclinical
RNAi-mediated downregulation of radiation-induced MMP-9 leads to apoptosis via activation of ERK and Akt in IOMM-Lee cells.
PMID 19082492·Int J Oncol·2009
8-other
The hemopexin domain of MMP-9 inhibits angiogenesis and retards the growth of intracranial glioblastoma xenograft in nude mice.
PMID 18942717·Int J Cancer·2009
7-preclinical
Human umbilical cord blood stem cells upregulate matrix metalloproteinase-2 in rats after spinal cord injury.
PMID 19631747·Neurobiol Dis·2009
7-preclinical
Malignant gliomas with primitive neuroectodermal tumor-like components: a clinicopathologic and genetic study of 53 cases.
PMID 18452568·Brain Pathol·2009
8-other
MMP-2 downregulation mediates differential regulation of cell death via ErbB-2 in glioma xenografts.
PMID 19578738·Int J Oncol·2009
7-preclinical
Stem cells downregulate the elevated levels of tissue plasminogen activator in rats after spinal cord injury.
PMID 19152029·Neurochem Res·2009
7-preclinical
uPA/uPAR downregulation inhibits radiation-induced migration, invasion and angiogenesis in IOMM-Lee meningioma cells and decreases tumor growth in vivo.
PMID 18949356·Int J Oncol·2008
7-preclinical
Downregulation of matrix metalloproteinase-2 (MMP-2) utilizing adenovirus-mediated transfer of small interfering RNA (siRNA) in a novel spinal metastatic melanoma model.
PMID 18292932·Int J Oncol·2008
7-preclinical
Umbilical cord blood stem cell mediated downregulation of fas improves functional recovery of rats after spinal cord injury.
PMID 17703359·Neurochem Res·2008
7-preclinical
Simultaneous downregulation of uPAR and MMP-9 induces overexpression of the FADD-associated protein RIP and activates caspase 9-mediated apoptosis in gliomas.
PMID 18813792·Int J Oncol·2008
8-other
Neuroprotection by cord blood stem cells against glutamate-induced apoptosis is mediated by Akt pathway.
PMID 18930139·Neurobiol Dis·2008
7-preclinical
Intraperitoneal injection of a hairpin RNA-expressing plasmid targeting urokinase-type plasminogen activator (uPA) receptor and uPA retards angiogenesis and inhibits intracranial tumor growth in nude mice.
PMID 17634529·Clin Cancer Res·2007
7-preclinical
MMP-9 short interfering RNA induced senescence resulting in inhibition of medulloblastoma growth via p16(INK4a) and mitogen-activated protein kinase pathway.
PMID 17510426·Cancer Res·2007
7-preclinical
RNA interference-mediated targeting of urokinase plasminogen activator receptor and matrix metalloproteinase-9 gene expression in the IOMM-lee malignant meningioma cell line inhibits tumor growth, tumor cell invasion and angiogenesis.
PMID 17549400·Int J Oncol·2007
7-preclinical
Down-regulation of uPAR and uPA activates caspase-mediated apoptosis and inhibits the PI3K/AKT pathway.
PMID 17549401·Int J Oncol·2007
8-other
Mesenchymal stem cells from rat bone marrow downregulate caspase-3-mediated apoptotic pathway after spinal cord injury in rats.
PMID 17564836·Neurochem Res·2007
7-preclinical
Restoration of tissue factor pathway inhibitor-2 in a human glioblastoma cell line triggers caspase-mediated pathway and apoptosis.
PMID 17575213·Clin Cancer Res·2007
8-other
RNAi-mediated abrogation of cathepsin B and MMP-9 gene expression in a malignant meningioma cell line leads to decreased tumor growth, invasion and angiogenesis.
PMID 17912429·Int J Oncol·2007
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 275 W MACARTHUR BLVD
OAKLAND, CA 94611 - Phone
- (510) 752-1000
Quick Facts
- NPI
- 1720230451
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 2
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile